Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
4863 participants
OBSERVATIONAL
2025-03-01
2026-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Postpartum Hemorrhage With Uterine Artery Doppler Measurement
NCT03229304
Predictors of Intrauterine Growth Restriction
NCT03349671
Fetal Doppler and Uterine Artery Blood Volume Correlation.
NCT05389553
Study on Doppler Ultrasound Measurement of Changes in Uterine Artery Blood Flow in Normal First Trimester Pregnancies and Its Prediction on Abortion
NCT06043804
the Efficacy of Fetal Arterial and Venous Doppler Indices in Predicting Perinatal Outcome
NCT05410080
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The following information will be recorded for each patient
* Age
* Body mass index (BMI)
* Ethnicity
* Parity
* Method of pregnancy onset (spontaneous vs. medically assisted procreation)
* Maternal pathologies (if any)
* Any foetal pathologies
* Ultrasound parameters in the second and third trimester of pregnancy
* Estimation of fetal weight
* Umbilical artery Doppler (UA-PI)
* Uterine artery Doppler (UtA-PI, UtA-RI and notch)
* Gestational age of fetal endouterine death
* Type of delivery
* Newborn and placental weight
* Histopathological findings of newborn and annexes (placenta and umbilical cord)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Obtaining informed consent form
Exclusion Criteria
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonio Farina, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
StUtDop1.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.